| # | Drug | Count |
|---|---|---|
| 0 | PREDNISONE | 28 |
| 1 | TACROLIMUS | 22 |
| 2 | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | 20 |
| 3 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 20 |
| 4 | TACROLIMUS OINTMENT 0.1% | 20 |
| 5 | MYCOPHENOLATE MOFETIL | 17 |
| 6 | RITUXIMAB | 14 |
| 7 | LAMIVUDINE | 11 |
| 8 | LAMIVUDINE ORAL | 11 |
| 9 | METHYLPREDNISOLONE | 11 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ASCORBIC ACID, THIAMINE, RIBOFLAVIN, NIACINAMIDE, PYRIDOXINE, FOLIC ACID, COBALAMIN, BIOTIN, PANTOTHENIC ACID | 1 | 0.0016 |
| 1 | DARUNAVIR ETHANOLATE AND COBICISTAT | 2 | 0.0011 |
| 2 | MARAVIROC | 2 | 0.0009 |
| 3 | DARUNAVIR 600 MG | 5 | 0.0008 |
| 4 | ETRAVIRINE | 3 | 0.0007 |
| 5 | DARUNAVIR | 9 | 0.0006 |
| 6 | COLLAGENASE SANTYL | 1 | 0.0006 |
| 7 | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | 20 | 0.0004 |
| 8 | LAMIVUDINE | 11 | 0.0004 |
| 9 | TECLISTAMAB-CQYV | 1 | 0.0004 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CCR5 Co-receptor Antagonist [EPC] | 2 | 0.0009 |
| 1 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 35 | 0.0003 |
| 2 | Antimetabolite Immunosuppressant [EPC] | 6 | 0.0003 |
| 3 | Cytochrome P450 3A Inhibitor [EPC] | 15 | 0.0002 |
| 4 | Protease Inhibitor [EPC] | 11 | 0.0002 |
| 5 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 12 | 0.0002 |
| 6 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 5 | 0.0002 |
| 7 | Human Immunoglobulin G [EPC] | 4 | 0.0002 |
| 8 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 4 | 0.0002 |
| 9 | Thymic Stromal Lymphopoietin Blocker [EPC] | 1 | 0.0001 |